Clinical Trial Update: Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide [NA]

View source ↗

Summary

Clinical trial update describing a study to reduce sarcopenia risk in adults with type 2 diabetes mellitus and obesity who are treated with semaglutide; the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Sarcopenia
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Sheba Medical Center | Conditions: Type 2 Diabetes Mellitus in Obese | NA | Status: NOT_YET_RECRUITING